|
|
sister chromatid cohesion
|
GO:0007062 |
2 |
0.174
|
|
|
|
notochord development
|
GO:0030903 |
54 |
0.130
|
|
|
|
head development
|
GO:0060322 |
303 |
0.089
|
|
|
|
chordate embryonic development
|
GO:0043009 |
271 |
0.088
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
274 |
0.085
|
|
|
|
cartilage condensation
|
GO:0001502 |
3 |
0.071
|
|
|
|
localization of cell
|
GO:0051674 |
244 |
0.070
|
|
|
|
negative regulation of biological process
|
GO:0048519 |
304 |
0.069
|
|
|
|
regulation of macromolecule metabolic process
|
GO:0060255 |
317 |
0.065
|
|
|
|
embryonic organ development
|
GO:0048568 |
381 |
0.065
|
|
|
|
cell motility
|
GO:0048870 |
244 |
0.061
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
97 |
0.061
|
|
|
|
biosynthetic process
|
GO:0009058 |
294 |
0.060
|
|
|
|
larval development
|
GO:0002164 |
2 |
0.055
|
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
271 |
0.055
|
|
|
|
embryonic cranial skeleton morphogenesis
|
GO:0048701 |
90 |
0.050
|
|
|
|
signal transduction
|
GO:0007165 |
455 |
0.049
|
|
|
|
stem cell maintenance
|
GO:0019827 |
4 |
0.049
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
4 |
0.048
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
231 |
0.047
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
93 |
0.046
|
|
|
|
cellular nitrogen compound metabolic process
|
GO:0034641 |
290 |
0.044
|
|
|
|
ear development
|
GO:0043583 |
127 |
0.043
|
|
|
|
regulation of nitrogen compound metabolic process
|
GO:0051171 |
251 |
0.043
|
|
|
|
regulation of primary metabolic process
|
GO:0080090 |
311 |
0.037
|
|
|
|
regulation of response to stimulus
|
GO:0048583 |
269 |
0.037
|
|
|
|
regulation of multicellular organism growth
|
GO:0040014 |
4 |
0.036
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
3 |
0.036
|
|
|
|
central nervous system development
|
GO:0007417 |
387 |
0.036
|
|
|
|
regulation of cellular biosynthetic process
|
GO:0031326 |
245 |
0.035
|
|
|
|
negative regulation of cellular process
|
GO:0048523 |
283 |
0.035
|
|
|
|
cell aggregation
|
GO:0098743 |
3 |
0.034
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
4 |
0.034
|
|
|
|
cell surface receptor signaling pathway
|
GO:0007166 |
325 |
0.034
|
|
|
|
digestive system development
|
GO:0055123 |
289 |
0.033
|
|
|
|
regulation of metabolic process
|
GO:0019222 |
359 |
0.033
|
|
|
|
single organism organelle organization
|
GO:1902589 |
199 |
0.032
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
2 |
0.031
|
|
|
|
mesenchymal cell proliferation
|
GO:0010463 |
1 |
0.031
|
|
|
|
cartilage development
|
GO:0051216 |
96 |
0.031
|
|
|
|
gene expression
|
GO:0010467 |
252 |
0.031
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
146 |
0.031
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
4 |
0.031
|
|
|
|
skeletal system development
|
GO:0001501 |
181 |
0.029
|
|
|
|
regulation of biosynthetic process
|
GO:0009889 |
250 |
0.029
|
|
|
|
response to stress
|
GO:0006950 |
263 |
0.029
|
|
|
|
negative regulation of dna metabolic process
|
GO:0051053 |
4 |
0.028
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
3 |
0.028
|
|
|
|
regulation of cellular metabolic process
|
GO:0031323 |
320 |
0.028
|
|
|
|
organic substance biosynthetic process
|
GO:1901576 |
289 |
0.027
|
|
|
|
multicellular organism growth
|
GO:0035264 |
4 |
0.027
|
|
|
|
locomotion
|
GO:0040011 |
313 |
0.027
|
|
|
|
organelle organization
|
GO:0006996 |
227 |
0.027
|
|
|
|
muscle tissue development
|
GO:0060537 |
110 |
0.027
|
|
|
|
meiotic chromosome segregation
|
GO:0045132 |
3 |
0.026
|
|
|
|
digestive tract development
|
GO:0048565 |
265 |
0.026
|
|
|
|
female gonad development
|
GO:0008585 |
4 |
0.026
|
|
|
|
cellular macromolecule metabolic process
|
GO:0044260 |
391 |
0.026
|
|
|
|
positive regulation of biological process
|
GO:0048518 |
253 |
0.026
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
4 |
0.026
|
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
2 |
0.025
|
|
|
|
lateral line development
|
GO:0048882 |
66 |
0.025
|
|
|
|
chromosome organization involved in meiosis
|
GO:0070192 |
1 |
0.025
|
|
|
|
macromolecule biosynthetic process
|
GO:0009059 |
227 |
0.025
|
|
|
|
cellular biosynthetic process
|
GO:0044249 |
286 |
0.025
|
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
1 |
0.024
|
|
|
|
nitrogen compound metabolic process
|
GO:0006807 |
319 |
0.024
|
|
|
|
cellular aromatic compound metabolic process
|
GO:0006725 |
295 |
0.024
|
|
|
|
negative regulation of dna replication
|
GO:0008156 |
2 |
0.024
|
|
|
|
sensory organ development
|
GO:0007423 |
393 |
0.023
|
|
|
|
heterocycle metabolic process
|
GO:0046483 |
290 |
0.023
|
|
|
|
membrane hyperpolarization
|
GO:0060081 |
1 |
0.023
|
|
|
|
cellular response to starvation
|
GO:0009267 |
1 |
0.023
|
|
|
|
immune system process
|
GO:0002376 |
241 |
0.023
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
2 |
0.023
|
|
|
|
aging
|
GO:0007568 |
2 |
0.022
|
|
|
|
regulation of gene expression
|
GO:0010468 |
265 |
0.022
|
|
|
|
metal ion transport
|
GO:0030001 |
58 |
0.022
|
|
|
|
cellular component movement
|
GO:0006928 |
335 |
0.022
|
|
|
|
regulation of signal transduction
|
GO:0009966 |
225 |
0.022
|
|
|
|
synaptic transmission cholinergic
|
GO:0007271 |
4 |
0.022
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
1 |
0.022
|
|
|
|
immune system development
|
GO:0002520 |
191 |
0.022
|
|
|
|
organic cyclic compound metabolic process
|
GO:1901360 |
301 |
0.022
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
2 |
0.021
|
|
|
|
connective tissue development
|
GO:0061448 |
99 |
0.021
|
|
|
|
cation transport
|
GO:0006812 |
81 |
0.021
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
3 |
0.021
|
|
|
|
negative regulation of signaling
|
GO:0023057 |
96 |
0.021
|
|
|
|
b cell activation
|
GO:0042113 |
2 |
0.021
|
|
|
|
neuromast development
|
GO:0048884 |
46 |
0.020
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
2 |
0.020
|
|
|
|
cell migration
|
GO:0016477 |
237 |
0.020
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
4 |
0.020
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
200 |
0.020
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
3 |
0.020
|
|
|
|
response to uv
|
GO:0009411 |
3 |
0.020
|
|
|
|
rna metabolic process
|
GO:0016070 |
219 |
0.020
|
|
|
|
angiogenesis
|
GO:0001525 |
158 |
0.019
|
|
|
|
regulation of rna metabolic process
|
GO:0051252 |
224 |
0.019
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
3 |
0.019
|
|
|
|
regionalization
|
GO:0003002 |
274 |
0.019
|
|
|
|
cellular macromolecule biosynthetic process
|
GO:0034645 |
224 |
0.019
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
1 |
0.019
|
|
|
|
regulation of cellular macromolecule biosynthetic process
|
GO:2000112 |
222 |
0.019
|
|
|
|
anterior posterior pattern specification
|
GO:0009952 |
152 |
0.019
|
|
|
|
lipid catabolic process
|
GO:0016042 |
4 |
0.019
|
|
|
|
mitotic sister chromatid cohesion
|
GO:0007064 |
2 |
0.019
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
2 |
0.019
|
|
|
|
aromatic compound biosynthetic process
|
GO:0019438 |
217 |
0.019
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
333 |
0.019
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
2 |
0.018
|
|
|
|
maintenance of location
|
GO:0051235 |
4 |
0.018
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
3 |
0.018
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
4 |
0.018
|
|
|
|
establishment of localization
|
GO:0051234 |
244 |
0.018
|
|
|
|
organic cyclic compound biosynthetic process
|
GO:1901362 |
223 |
0.018
|
|
|
|
segmentation
|
GO:0035282 |
97 |
0.018
|
|
|
|
adult behavior
|
GO:0030534 |
2 |
0.018
|
|
|
|
synaptic target recognition
|
GO:0008039 |
1 |
0.017
|
|
|
|
negative regulation of cell communication
|
GO:0010648 |
96 |
0.017
|
|
|
|
nucleic acid metabolic process
|
GO:0090304 |
244 |
0.017
|
|
|
|
somitogenesis
|
GO:0001756 |
87 |
0.017
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
4 |
0.017
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
191 |
0.017
|
|
|
|
protein acetylation
|
GO:0006473 |
2 |
0.017
|
|
|
|
transcription dna templated
|
GO:0006351 |
181 |
0.016
|
|
|
|
programmed cell death
|
GO:0012501 |
119 |
0.016
|
|
|
|
regeneration
|
GO:0031099 |
91 |
0.016
|
|
|
|
cellular nitrogen compound biosynthetic process
|
GO:0044271 |
218 |
0.016
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
3 |
0.016
|
|
|
|
regulation of multicellular organismal development
|
GO:2000026 |
223 |
0.016
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
3 |
0.016
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
1 |
0.016
|
|
|
|
dorsal ventral pattern formation
|
GO:0009953 |
125 |
0.016
|
|
|
|
pharyngeal system development
|
GO:0060037 |
18 |
0.016
|
|
|
|
ion transport
|
GO:0006811 |
114 |
0.016
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
1 |
0.016
|
|
|
|
regulation of multicellular organismal process
|
GO:0051239 |
277 |
0.016
|
|
|
|
regulation of macromolecule biosynthetic process
|
GO:0010556 |
225 |
0.016
|
|
|
|
epiboly
|
GO:0090504 |
41 |
0.015
|
|
|
|
negative regulation of nitrogen compound metabolic process
|
GO:0051172 |
59 |
0.015
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
3 |
0.015
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
107 |
0.015
|
|
|
|
positive regulation of transport
|
GO:0051050 |
2 |
0.015
|
|
|
|
negative regulation of macromolecule metabolic process
|
GO:0010605 |
76 |
0.015
|
|
|
|
regulation of apoptotic process
|
GO:0042981 |
98 |
0.015
|
|
|
|
nucleic acid templated transcription
|
GO:0097659 |
181 |
0.015
|
|
|
|
regulation of cell communication
|
GO:0010646 |
232 |
0.015
|
|
|
|
negative regulation of response to stimulus
|
GO:0048585 |
104 |
0.015
|
|
|
|
regulation of developmental process
|
GO:0050793 |
247 |
0.015
|
|
|
|
transport
|
GO:0006810 |
220 |
0.015
|
|
|
|
blood vessel development
|
GO:0001568 |
246 |
0.015
|
|
|
|
regulation of transcription dna templated
|
GO:0006355 |
213 |
0.015
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
63 |
0.015
|
|
|
|
tube morphogenesis
|
GO:0035239 |
349 |
0.015
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
2 |
0.015
|
|
|
|
vasculature development
|
GO:0001944 |
278 |
0.015
|
|
|
|
antimicrobial humoral response
|
GO:0019730 |
2 |
0.015
|
|
|
|
regulation of signaling
|
GO:0023051 |
235 |
0.015
|
|
|
|
nucleobase containing compound biosynthetic process
|
GO:0034654 |
205 |
0.015
|
|
|
|
protein dephosphorylation
|
GO:0006470 |
3 |
0.015
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
2 |
0.015
|
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
2 |
0.015
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
244 |
0.015
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
246 |
0.015
|
|
|
|
response to monosaccharide
|
GO:0034284 |
3 |
0.015
|
|
|
|
rna biosynthetic process
|
GO:0032774 |
181 |
0.014
|
|
|
|
otic vesicle development
|
GO:0071599 |
42 |
0.014
|
|
|
|
determination of dorsal ventral asymmetry
|
GO:0048262 |
34 |
0.014
|
|
|
|
endochondral bone growth
|
GO:0003416 |
2 |
0.014
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
1 |
0.014
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
1 |
0.014
|
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
2 |
0.014
|
|
|
|
gastrulation
|
GO:0007369 |
208 |
0.014
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
216 |
0.014
|
|
|
|
positive regulation of canonical wnt signaling pathway
|
GO:0090263 |
4 |
0.014
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
2 |
0.014
|
|
|
|
chondrocyte development
|
GO:0002063 |
4 |
0.014
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
4 |
0.014
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
336 |
0.014
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
1 |
0.014
|
|
|
|
regulation of cell activation
|
GO:0050865 |
1 |
0.014
|
|
|
|
protein acylation
|
GO:0043543 |
3 |
0.013
|
|
|
|
atp catabolic process
|
GO:0006200 |
4 |
0.013
|
|
|
|
histone h3 k4 methylation
|
GO:0051568 |
2 |
0.013
|
|
|
|
regulation of transmembrane transporter activity
|
GO:0022898 |
2 |
0.013
|
|
|
|
female sex differentiation
|
GO:0046660 |
4 |
0.013
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
3 |
0.013
|
|
|
|
negative regulation of signal transduction
|
GO:0009968 |
94 |
0.013
|
|
|
|
response to carbohydrate
|
GO:0009743 |
3 |
0.013
|
|
|
|
hemopoiesis
|
GO:0030097 |
183 |
0.013
|
|
|
|
amide biosynthetic process
|
GO:0043604 |
1 |
0.013
|
|
|
|
positive regulation of striated muscle cell differentiation
|
GO:0051155 |
1 |
0.013
|
|
|
|
cell cell recognition
|
GO:0009988 |
1 |
0.013
|
|
|
|
regulation of binding
|
GO:0051098 |
3 |
0.013
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
2 |
0.013
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
4 |
0.013
|
|
|
|
monoamine transport
|
GO:0015844 |
1 |
0.013
|
|
|
|
nucleobase containing compound metabolic process
|
GO:0006139 |
274 |
0.013
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
4 |
0.013
|
|
|
|
response to alkaloid
|
GO:0043279 |
2 |
0.013
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
2 |
0.013
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
2 |
0.013
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
4 |
0.013
|
|
|
|
mononuclear cell proliferation
|
GO:0032943 |
1 |
0.013
|
|
|
|
cell morphogenesis
|
GO:0000902 |
289 |
0.013
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
1 |
0.013
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
2 |
0.012
|
|
|
|
regulation of response to biotic stimulus
|
GO:0002831 |
2 |
0.012
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
3 |
0.012
|
|
|
|
positive regulation of cellular process
|
GO:0048522 |
201 |
0.012
|
|
|
|
negative regulation of intracellular transport
|
GO:0032387 |
3 |
0.012
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
1 |
0.012
|
|
|
|
regulation of dna replication
|
GO:0006275 |
3 |
0.012
|
|
|
|
negative regulation of immune response
|
GO:0050777 |
2 |
0.012
|
|
|
|
regulation of filopodium assembly
|
GO:0051489 |
2 |
0.012
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
4 |
0.012
|
|
|
|
specification of organ identity
|
GO:0010092 |
2 |
0.012
|
|
|
|
regulation of rna biosynthetic process
|
GO:2001141 |
213 |
0.012
|
|
|
|
sprouting angiogenesis
|
GO:0002040 |
53 |
0.012
|
|
|
|
secondary metabolic process
|
GO:0019748 |
3 |
0.012
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
2 |
0.012
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
2 |
0.012
|
|
|
|
negative regulation of gene expression
|
GO:0010629 |
65 |
0.012
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
1 |
0.012
|
|
|
|
protein import
|
GO:0017038 |
3 |
0.012
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
102 |
0.012
|
|
|
|
positive regulation of small gtpase mediated signal transduction
|
GO:0051057 |
1 |
0.012
|
|
|
|
regulation of axon extension
|
GO:0030516 |
24 |
0.012
|
|
|
|
negative regulation of nuclear division
|
GO:0051784 |
3 |
0.012
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
1 |
0.012
|
|
|
|
muscle structure development
|
GO:0061061 |
196 |
0.012
|
|
|
|
intracellular signal transduction
|
GO:0035556 |
85 |
0.012
|
|
|
|
mitochondrion organization
|
GO:0007005 |
4 |
0.012
|
|
|
|
response to nicotine
|
GO:0035094 |
2 |
0.011
|
|
|
|
cell projection organization
|
GO:0030030 |
284 |
0.011
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
3 |
0.011
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
4 |
0.011
|
|
|
|
response to hexose
|
GO:0009746 |
3 |
0.011
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
4 |
0.011
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
2 |
0.011
|
|
|
|
inner ear development
|
GO:0048839 |
126 |
0.011
|
|
|
|
brain development
|
GO:0007420 |
293 |
0.011
|
|
|
|
lipid homeostasis
|
GO:0055088 |
3 |
0.011
|
|
|
|
notochord morphogenesis
|
GO:0048570 |
17 |
0.011
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
3 |
0.011
|
|
|
|
chromosome organization
|
GO:0051276 |
31 |
0.011
|
|
|
|
positive regulation of translation
|
GO:0045727 |
1 |
0.011
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
4 |
0.011
|
|
|
|
regulation of nucleobase containing compound metabolic process
|
GO:0019219 |
250 |
0.011
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
3 |
0.011
|
|
|
|
regulation of alternative mrna splicing via spliceosome
|
GO:0000381 |
1 |
0.011
|
|
|
|
fin development
|
GO:0033333 |
77 |
0.011
|
|
|
|
spinal cord anterior posterior patterning
|
GO:0021512 |
1 |
0.011
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
4 |
0.011
|
|
|
|
regulation of programmed cell death
|
GO:0043067 |
101 |
0.011
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
4 |
0.011
|
|
|
|
stem cell proliferation
|
GO:0072089 |
4 |
0.011
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
3 |
0.011
|
|
|
|
cellular component biogenesis
|
GO:0044085 |
178 |
0.011
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
3 |
0.011
|
|
|
|
developmental growth
|
GO:0048589 |
166 |
0.011
|
|
|
|
eye morphogenesis
|
GO:0048592 |
144 |
0.011
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
31 |
0.011
|
|
|
|
negative regulation of metabolic process
|
GO:0009892 |
86 |
0.011
|
|
|
|
protein modification by small protein removal
|
GO:0070646 |
1 |
0.011
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
3 |
0.011
|
|
|
|
regulation of postsynaptic membrane potential
|
GO:0060078 |
1 |
0.011
|
|
|
|
transcription from rna polymerase ii promoter
|
GO:0006366 |
80 |
0.011
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
1 |
0.011
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
2 |
0.011
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
1 |
0.011
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
32 |
0.011
|
|
|
|
somatic muscle development
|
GO:0007525 |
4 |
0.011
|
|
|
|
neural retina development
|
GO:0003407 |
49 |
0.011
|
|
|
|
generation of neurons
|
GO:0048699 |
385 |
0.011
|
|
|
|
exocytosis
|
GO:0006887 |
1 |
0.011
|
|
|
|
eye development
|
GO:0001654 |
277 |
0.011
|
|
|
|
negative regulation of cellular metabolic process
|
GO:0031324 |
77 |
0.011
|
|
|
|
sensory system development
|
GO:0048880 |
76 |
0.010
|
|
|
|
superoxide metabolic process
|
GO:0006801 |
2 |
0.010
|
|
|
|
positive regulation of protein polymerization
|
GO:0032273 |
2 |
0.010
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
1 |
0.010
|
|
|
|
apoptotic process involved in morphogenesis
|
GO:0060561 |
2 |
0.010
|
|
|
|
ribosomal small subunit biogenesis
|
GO:0042274 |
2 |
0.010
|
|
|
|
phagocytosis
|
GO:0006909 |
3 |
0.010
|
|
|
|
epiboly involved in gastrulation with mouth forming second
|
GO:0055113 |
35 |
0.010
|
|
|
|
post embryonic organ development
|
GO:0048569 |
4 |
0.010
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
22 |
0.010
|
|
|
|
regulation of tube size
|
GO:0035150 |
2 |
0.010
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
2 |
0.010
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
86 |
0.010
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
1 |
0.010
|
|
|
|
regulation of skeletal muscle tissue development
|
GO:0048641 |
4 |
0.010
|
|
|
|
cellular respiration
|
GO:0045333 |
3 |
0.010
|
|
|
|
fat soluble vitamin metabolic process
|
GO:0006775 |
4 |
0.010
|
|
|
|
gastrulation with mouth forming second
|
GO:0001702 |
44 |
0.010
|
|
|
|
protein metabolic process
|
GO:0019538 |
183 |
0.010
|
|
|
|
neuron neuron synaptic transmission
|
GO:0007270 |
1 |
0.010
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
4 |
0.010
|
|